|
TEAD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.038400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.798000E-01 |
| Normal-vs-Stage2 |
5.731800E-01 |
| Normal-vs-Stage3 |
5.120800E-01 |
| Normal-vs-Stage4 |
2.692600E-01 |
| Stage1-vs-Stage2 |
3.583200E-01 |
| Stage1-vs-Stage3 |
2.640400E-01 |
| Stage1-vs-Stage4 |
2.153200E-01 |
| Stage2-vs-Stage3 |
9.596800E-01 |
| Stage2-vs-Stage4 |
5.831000E-01 |
| Stage3-vs-Stage4 |
6.027000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.594400E-01 |
| Normal-vs-AfricanAmerican |
7.756200E-01 |
| Normal-vs-Asian |
6.720800E-01 |
| Caucasian-vs-AfricanAmerican |
9.281800E-01 |
| Caucasian-vs-Asian |
6.148000E-01 |
| AfricanAmerican-vs-Asian |
6.048600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.511400E-01 |
| Normal-vs-Female |
1.936350E-01 |
| Male-vs-Female |
5.900000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.981800E-01 |
| Normal-vs-Extreme_Weight |
8.955000E-01 |
| Normal-vs-Obese |
3.313600E-01 |
| Normal-vs-Extreme_Obese |
3.968600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.846600E-01 |
| Normal_Weight-vs-Obese |
4.488400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.555600E-01 |
| Extreme_Weight-vs-Obese |
3.477800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.274400E-01 |
| Obese-vs-Extreme_Obese |
2.505000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.544800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.280850E-01 |
| Normal-vs-Age(61-80Yrs) |
6.588600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.438200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.869000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.849380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.257500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.060500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.365800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.538650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.572090E-02 |
| Normal-VS-Type2 PRCC |
1.742590E-03 |
| Normal-VS-KIRP CIMP |
5.789800E-02 |
| Normal-VS-Unclassified PRCC |
9.726400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.91550125655726E-11 |
| Type1 PRCC-VS-KIRP CIMP |
6.018400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.326400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.826800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.535850E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.517900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.250200E-01 |
| Normal-vs-N1 |
4.570600E-01 |
| Normal-vs-N2 |
8.453600E-01 |
| N0-vs-N1 |
6.369400E-01 |
| N0-vs-N2 |
3.925000E-01 |
| N1-vs-N2 |
6.250200E-01 |
|
|
